Human Papillomavirus Vaccination Status and Parental Endorsement Intentions among Undergraduate Student Nurses

We identified factors associated with student nurses’ Human Papillomavirus Vaccine (HPV) vaccination status and their intention to counsel parents on HPV vaccination. Undergraduate student nurses (N = 153) from a large university in the south participated. Descriptive statistics, chi-squared tests, and independent t-tests (p ≤ 0.05) were used to characterize the students’ vaccination status. Logistic regression was used to identify factors associated with vaccination status. HPV vaccination rates were low. Students who were older and married or living with a partner were less likely to have completed the HPV vaccine series. The most commonly cited reason for non-initiation and non-completion was the lack of provider endorsement. Vaccination status did not differ significantly according to race/ethnicity, religion, skills, or intention to counsel parents. While intentions to counsel parents on HPV vaccination are high among student nurses, interventions to improve vaccination rates among student nurses are needed.

Download Full-text

Vaccipack, A Mobile App to Promote Human Papillomavirus Vaccine Uptake Among Adolescents Aged 11 to 14 Years: Development and Usability Study

JMIR Nursing ◽

10.2196/19503 ◽

2020 ◽

Vol 3 (1) ◽

pp. e19503

Author(s):

Anne M Teitelman ◽

Emily F Gregory ◽

Joshua Jayasinghe ◽

Zara Wermers ◽

Ja H Koo ◽

...

Keyword(s):

Human Papillomavirus ◽

Technology Acceptance ◽

Hpv Vaccine ◽

Hpv Vaccination ◽

Behavioral Model ◽

The United States ◽

Mobile App ◽

Vaccine Uptake ◽

Human Papillomavirus Vaccine ◽

Vaccination Rates

Background More than 90% of human papillomavirus (HPV)-related cancers could be prevented by widespread uptake of the HPV vaccine, yet vaccine use in the United States falls short of public health goals. Objective The purpose of this study was to describe the development, acceptability, and intention to use the mobile app Vaccipack, which was designed to promote uptake and completion of the adolescent HPV vaccine series. Methods Development of the mobile health (mHealth) content was based on the integrated behavioral model (IBM). The technology acceptance model (TAM) was used to guide the app usability evaluation. App design utilized an iterative process involving providers and potential users who were parents and adolescents. App features include a vaccine-tracking function, a discussion forum, and stories with embedded messages to promote intention to vaccinate. Parents and adolescents completed surveys before and after introducing the app in a pediatric primary care setting with low HPV vaccination rates. Results Surveys were completed by 54 participants (20 adolescents aged 11 to 14 years and 34 parents). Notably, 75% (15/20) of adolescents and 88% (30/34) of parents intended to use the app in the next 2 weeks. Acceptability of the app was high among both groups: 88% (30/34) of parents and 75% (15/20) of adolescents indicated that Vaccipack was easy to use, and 82% (28/34) of parents and 85% (17/20) of adolescents perceived the app to be beneficial. Higher levels of app acceptability were found among parents with strong intentions to use the app (P=.09; 95% CI –2.15 to 0.15). Conclusions mHealth technology, such as Vaccipack, may be an acceptable and nimble platform for providing information to parents and adolescents and advancing the uptake of important vaccines.

Download Full-text

Quadrivalent human papillomavirus vaccination successfully reduces the prevalence of vaccine-targeted genotypes in a young, vaccine-eligible-age sample of Australian females

Sexual Health ◽

10.1071/sh20033 ◽

2020 ◽

Vol 17 (6) ◽

pp. 510

Author(s):

Asvini K. Subasinghe ◽

John D. Wark ◽

Samuel Phillips ◽

Alyssa Cornall ◽

Julia M. L. Brotherton ◽

...

Keyword(s):

Human Papillomavirus ◽

Sexual Debut ◽

Hpv Vaccination ◽

Sexual Partners ◽

Vaccination Status ◽

Vaccine Uptake ◽

Early Sexual Debut ◽

Multiple Sexual Partners ◽

Hpv Dna ◽

Factors Associated

Background The prevalence of genital tract vaccine-type human papillomavirus (HPV) is on the decline due to high vaccine uptake through the national HPV immunisation program in Australia. The aim of this study was to investigate HPV vaccine coverage and factors associated with HPV in a vaccine-eligible sample of young Australian females. Methods: Females aged 16–25 years were recruited into the Young Female Health Initiative study, a young women’s health study, via Facebook advertising from 2012 to 2017. Sexually active participants were asked to provide a self-collected vaginal swab for the detection of HPV DNA; positive samples were genotyped. Self-reported HPV vaccination status was confirmed by the National HPV Vaccination Program Register. Outcomes of the study were HPV acquisition and genotype, HPV vaccination status and factors associated with HPV. Results: Overall, 22.8% of samples (95% confidence interval (CI) 17.8–27.8%; n = 62/272) were positive for any HPV DNA, of which 19.1% (95% CI 14.4–23.8%; n = 52/272) were oncogenic types. HPV 16 was detected in three samples (1.1%; 95% CI –0.1%, 2.3%; two not HPV vaccinated and one vaccinated after sexual debut). Early sexual debut (<16 years) and multiple sexual partners were independently associated with an increased risk of any HPV. Conclusions: In a community sample of vaccine-eligible-age females with a high vaccine uptake, the prevalence of vaccine-related HPV genotypes is extremely low. Early sexual debut and multiple sexual partners are positively associated with HPV, underscoring the importance of vaccination at the routinely recommended age of 12–13 years for best vaccine impact.

Download Full-text

Parental beliefs and knowledge about male human papillomavirus vaccination in the US: a survey of a pediatric clinic population

International Journal of Adolescent Medicine and Health ◽

10.1515/ijamh.2012.045 ◽

2012 ◽

Vol 24 (4) ◽

pp. 315-320 ◽

Cited By ~ 5

Author(s):

Meridith Griebeler ◽

Helayne Feferman ◽

Vibha Gupta ◽

Dilip Patel

Keyword(s):

Human Papillomavirus ◽

Health Outcomes ◽

Hpv Vaccination ◽

Parental Knowledge ◽

Parental Beliefs ◽

Human Papillomavirus Vaccination ◽

Actual Knowledge ◽

Vaccination Rates ◽

Knowledge And Beliefs ◽

Clinic Population

Abstract The purpose of this study is to examine US parental knowledge of human papillomavirus (HPV) in males, views on vaccination, and correlation to vaccination rates. The survey was conducted of clinic population about parental knowledge and beliefs of male HPV health outcomes and vaccination. There were a total of 102 participants who completed the survey. Perceived parental knowledge about the virus was reported as “a lot” by 11%, “some” by 50%, and “very little/nothing” by 38% of the participants. However, knowledge of HPV was moderate, with only 14% of the respondents answering all knowledge questions correctly; 64% of the respondents correctly identified HPV as a cause of genital warts in males, 43% identified at least one HPV-related cancer, and 30% were unable to identify any health outcomes in males. There was a statistically significant correlation between perceived and actual knowledge, with >15% of the survey respondents correctly identifying that HPV does not clear up on its own (p=0.004). Of the participants who did not vaccinate, reasons included the following: 54% fulfilled the child’s wish not to be vaccinated, 38% reported belief vaccine is unsafe, and 38% indicated that their children are too young and/or expressed fear that the vaccine would negatively affect behavior. This study supports the fact that parental beliefs and attitudes are more important than actual knowledge about HPV or HPV vaccination. The implication to physicians is to tailor discussions to address fears about the dangers or complications, emphasize the safety of the vaccine, and address sources of misinformation.

Download Full-text

Human Papillomavirus Vaccine Course Completion Among Gay and Bisexual Men Who Have Sex With Men From a Time-Limited HPV Vaccination Catch-Up Program in Victoria, Australia

Frontiers in Public Health ◽

10.3389/fpubh.2021.754112 ◽

2021 ◽

Vol 9 ◽

Author(s):

Kay Htaik ◽

Christopher K. Fairley ◽

Marcus Y. Chen ◽

Rebecca Wigan ◽

Elena Rodriguez ◽

...

Keyword(s):

Human Papillomavirus ◽

Hpv Vaccine ◽

Hpv Vaccination ◽

Health Centre ◽

Bisexual Men ◽

Human Papillomavirus Vaccine ◽

Factors Associated ◽

Catch Up ◽

Sex With Men ◽

Hiv Negative

Background: To examine completion of the human papillomavirus (HPV) vaccination 3-dose regimen and factors associated with completion among men who have sex with men (MSM) aged ≤ 26 years participating in a time-limited HPV catch-up vaccination program in Victoria, Australia.Methods: MSM who received their first dose of HPV vaccine at Melbourne Sexual Health Centre in 2017 were followed until October 2019. Vaccination completion was defined as those who received three doses. Multivariable logistic regression was performed to examine factors associated with vaccine completion.Results: 931 of 1,947 (47.8%) eligible men received at least one dose of HPV vaccine, 750 (38.5%) received two and 590 (30.3%) received three doses. The median time to receiving the second and third dose was 2.8 (IQR = 2.1–4.8) and 7.2 (IQR = 6.3–10.7) months, respectively. Gay men had higher odds of receiving three doses compared to bisexual men (aOR = 2.17; 95%CI: 1.16–4.04). Compared with HIV-negative MSM not taking PrEP, HIV-positive MSM were more like to complete vaccination (aOR = 3.92, 95%CI: 1.62–9.47) but no difference was found compared to HIV-negative men taking PrEP (aOR = 1.55; 95%CI: 0.95–2.53).Conclusion: Less than one-third of men aged ≤ 26 years completed the three doses of HPV vaccine. Further studies are needed to understand the barriers of men not completing the vaccine.

Download Full-text

2558 Current efforts to increase adolescent human papillomavirus vaccination rates using school-based setting in Starr County, Texas

Journal of Clinical and Translational Science ◽

10.1017/cts.2018.246 ◽

2018 ◽

Vol 2 (S1) ◽

pp. 67-67

Author(s):

Ana Marina Rodriguez ◽

Kathleen Schmeler ◽

Sapna Kaul ◽

Yong-Fang Kuo

Keyword(s):

Human Papillomavirus ◽

Hpv Vaccine ◽

Hpv Vaccination ◽

Parental Knowledge ◽

Completion Rates ◽

Human Papillomavirus Vaccination ◽

Parent Survey ◽

Independent School District ◽

Vaccination Rates ◽

School Based

OBJECTIVES/SPECIFIC AIMS: Improving human papillomavirus (HPV) vaccination rates ultimately decreases the morbidity and mortality of HPV-associated diseases. A school-based program was piloted in the Rio Grande City Consolidated Independent School District (RGCCISD) to increase HPV vaccination. METHODS/STUDY POPULATION: We assessed baseline HPV vaccination; surveyed 622 parents of eligible children aged ≥9 years; and piloted and developed a school-based HPV education and vaccination program in 1 middle school in 2017 and 4 additional middle schools in 2018. The parent survey included (1) demographic information, (2) an assessment of parental knowledge about the HPV vaccine, and (3) information about their children and HPV vaccine experience. Results of the parent survey and pilot program are in progress. RESULTS/ANTICIPATED RESULTS: As of 9/1/2016, 20.4% of the 7527 RGCCISD eligible students (≥9 years) had completed the HPV vaccine. Baseline completion rates were higher for RGCCISD students aged 12–14 years compared with students aged 9–11 and ≥15 years (28.4% vs. 16.5%). Baseline completion rates for RGCCISD adolescents were substantially lower than those reported in NIS-Teen and for Texas (42% females and 28% males for NIS-Teen vs. 41% and 24% for the state of Texas). DISCUSSION/SIGNIFICANCE OF IMPACT: Initial results show that engagement with key stakeholders is important and schools are a great venue for delivering and increasing HPV vaccination.

Download Full-text

Vaccipack, A Mobile App to Promote Human Papillomavirus Vaccine Uptake Among Adolescents Aged 11 to 14 Years: Development and Usability Study (Preprint)

10.2196/preprints.19503 ◽

2020 ◽

Author(s):

Anne M Teitelman ◽

Emily F Gregory ◽

Joshua Jayasinghe ◽

Zara Wermers ◽

Ja H Koo ◽

...

Keyword(s):

Human Papillomavirus ◽

Technology Acceptance ◽

Hpv Vaccine ◽

Hpv Vaccination ◽

Behavioral Model ◽

The United States ◽

Mobile App ◽

Vaccine Uptake ◽

Human Papillomavirus Vaccine ◽

Vaccination Rates

BACKGROUND More than 90% of human papillomavirus (HPV)-related cancers could be prevented by widespread uptake of the HPV vaccine, yet vaccine use in the United States falls short of public health goals. OBJECTIVE The purpose of this study was to describe the development, acceptability, and intention to use the mobile app Vaccipack, which was designed to promote uptake and completion of the adolescent HPV vaccine series. METHODS Development of the mobile health (mHealth) content was based on the integrated behavioral model (IBM). The technology acceptance model (TAM) was used to guide the app usability evaluation. App design utilized an iterative process involving providers and potential users who were parents and adolescents. App features include a vaccine-tracking function, a discussion forum, and stories with embedded messages to promote intention to vaccinate. Parents and adolescents completed surveys before and after introducing the app in a pediatric primary care setting with low HPV vaccination rates. RESULTS Surveys were completed by 54 participants (20 adolescents aged 11 to 14 years and 34 parents). Notably, 75% (15/20) of adolescents and 88% (30/34) of parents intended to use the app in the next 2 weeks. Acceptability of the app was high among both groups: 88% (30/34) of parents and 75% (15/20) of adolescents indicated that Vaccipack was easy to use, and 82% (28/34) of parents and 85% (17/20) of adolescents perceived the app to be beneficial. Higher levels of app acceptability were found among parents with strong intentions to use the app (<i>P</i>=.09; 95% CI –2.15 to 0.15). CONCLUSIONS mHealth technology, such as Vaccipack, may be an acceptable and nimble platform for providing information to parents and adolescents and advancing the uptake of important vaccines.

Download Full-text

A multimodal approach to improving human papillomavirus vaccination in a community pharmacy setting

SAGE Open Medicine ◽

10.1177/2050312116682128 ◽

2016 ◽

Vol 4 ◽

pp. 205031211668212 ◽

Cited By ~ 4

Author(s):

Kenneth C Hohmeier ◽

Donna D Randolph ◽

Cindy Taliaferro Smith ◽

Tracy M Hagemann

Keyword(s):

Human Papillomavirus ◽

Community Pharmacy ◽

Control Period ◽

Educational Interventions ◽

Human Papillomavirus Vaccine ◽

Human Papillomavirus Vaccination ◽

Community Based Research ◽

Vaccination Rates ◽

The Impact ◽

Pharmacy Setting

Background: Community pharmacy has become a major access point for several types of vaccinations. Despite the success of vaccination programs like influenza, pneumococcal, and herpes zoster, the rates of human papillomavirus vaccination continue to lag. Objectives: The primary objective is to describe and report on the impact of a multimodal series of pharmacist-led educational interventions on human papillomavirus vaccination rates in a community pharmacy setting. The primary outcome of this study was change in pharmacist-delivered human papillomavirus vaccination throughout a corresponding 8-week period in 2014 and 2015. Methods: A single-center, quasi-experimental interrupted time series mixed-methods pilot study was used to investigate a pharmacist-led, multimodal educational intervention approach to improve human papillomavirus vaccination rates in the community. Results: During the 2014 control period, there were no human papillomavirus vaccines dispensed or administered according to the internal prescription dispensing software. In 2015, a total of 10 patients indicated that they were vaccinated, with 9 patients receiving their first dose and 1 patient receiving his or her second dose at the pharmacy. Pharmacist recommendation was the most reported education method for increasing patient awareness of the human papillomavirus vaccine (n = 10). Conclusion: This study demonstrates pharmacist designed, educational interventions may impact human papillomavirus vaccination rates in the community. Further community-based research with larger sample sizes is warranted to verify these results. Due to the unique barriers to human papillomavirus vaccination, a multimodal and inter-professional approach such as the one presented here is warranted.

Download Full-text

Factors Associated with Human Papillomavirus Vaccination Status at U.S. Colleges and Universities

Health & Social Work ◽

10.1093/hsw/hlw050 ◽

2016 ◽

Vol 42 (1) ◽

pp. e1-e7 ◽

Cited By ~ 9

Author(s):

Vetta L. Sanders Thompson ◽

Sheretta T. Butler-Barnes ◽

Brittni D. Jones ◽

Anjanette A. Wells ◽

Renee M. Cunningham-Williams ◽

...

Keyword(s):

Human Papillomavirus ◽

Colleges And Universities ◽

Vaccination Status ◽

Human Papillomavirus Vaccination ◽

Factors Associated

Download Full-text

Betwixt and Between Well and Sick in Cervical Precancer: Canadian Women’s Experiences of Recurring HPV Infections and HPV Vaccination

Canadian Journal of Nursing Research ◽

10.1177/0844562118763496 ◽

2018 ◽

Vol 50 (3) ◽

pp. 120-132 ◽

Cited By ~ 2

Author(s):

Michelle Wyndham-West ◽

Nancy Durand ◽

Aimee Santoro

Keyword(s):

Cervical Cancer ◽

Human Papillomavirus ◽

Hpv Vaccination ◽

Self Care ◽

Human Papillomavirus Vaccine ◽

Papillomavirus Infections ◽

Human Papillomavirus Vaccination ◽

Cervical Cancer Risk ◽

Cervical Precancer ◽

Medical Histories

Background This research fuses the experiences of a precancer diagnosis with the decision-making surrounding a vaccine that can protect against human papillomavirus strains that women may not have been exposed to. The interviewee cohort is of note as half the women were in their 30s and 40s and 75% were over the age of 26. These groupings are often overlooked in media discourses and narrative research surrounding human papillomavirus and the human papillomavirus vaccine. Purpose Womens’ diagnoses and treatment experiences, including colposcopies, biopsies, and Loop Electrosurgical Excision Procedures, are chronicled to highlight a liminal, precancerous state—one in which they are not deemed healthy, but nor have they been diagnosed with cancer. These are emotion-filled experiences that are ridden with anxiety and fear, but also ones that are structured with self-care strategies to contain human papillomavirus infections and the risk of cervical cancer. Methods Twenty women who attended Sunnybrook Health Sciences Centre’s human papillomavirus vaccination clinic were interviewed and their narratives were documented and analyzed to determine their experiences surrounding human papillomavirus infections and precancer as well as their motivations for human papillomavirus vaccination. Results The decision to undergo human papillomavirus vaccination was a self-care strategy that accompanied treatment procedures and was a means to reduce cervical cancer risk. While encouraged with the human papillomavirus vaccine’s potential to curb cervical cancer, they had a tempered view of the vaccine and its effectiveness in their cases, given their medical histories. Conclusions The research provides an in-depth accounting of an often overlooked grouping in human papillomavirus and human papillomavirus vaccination research and media discourse which, generally, focuses upon middle-school-aged girls and university-/college-aged women. In addition, the research provides recommendations for practice for cervical precancer diagnoses going forward.

Download Full-text